Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy

NCT04166604 is registered in ClinicalTrials.gov with GERCOR - Multidisciplinary Oncology Cooperative Group as lead sponsor.

NCT NCT04166604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04166604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy
Lead sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 20, 2020
Completion date
November 30, 2025
Enrollment
176 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer